Skip to content

The role of endoscopic dilation and stents in refractory benign esophageal strictures: a retrospective analysis.

The role of endoscopic dilation and stents in benign esophageal strictures.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016321
Enrollment
Unknown
Registered
2018-05-25
Start date
2018-05-17
Completion date
Unknown
Last updated
2018-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory esophageal stricture

Interventions

one:dilaiton
two:stent

Sponsors

West China hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) they had been diagnosed with esophageal benign stricture according to clinical manifestation, gastroscopy, and pathology; (2) they had persistent symptoms of dysphagia despite = three sessions of endoscopic therapy, and (3) they had complete medical records and follow-up information, including gender, age at first therapy, RBES etiology, number, location, length and diameter of structures, endoscopic therapy, the period between two consecutive endoscopic interventions, and adverse events.

Exclusion criteria

Exclusion criteria: (1) younger than 16 years old; (2) had received<3 endoscopic interventions; (3) had been diagnosed with congenital esophageal stenosis, malignant esophageal strictures, or with esophageal fistula.

Design outcomes

Primary

MeasureTime frame
dysphagia-free;

Countries

China

Contacts

Public ContactMa Hongsheng

West China Hospital, Sichuan University

13438030687@163.com+86 13438030687

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 21, 2026